CB-103 Uses, Dosage, Side Effects and more
CB-103 is under investigation in clinical trial NCT03422679 (Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies).
| Attribute | Details |
|---|---|
| Trade Name | CB-103 |
| Generic | CB-103 |
| Type | |
| Formula | C15H18N2O |
| Weight | Average: 242.322 Monoisotopic: 242.141913208 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
